The US develops a vaccine to deal with a new CoV strain
The US develops a vaccine to deal with a new CoV strain news Debbie Elrick 29 Jan 2021 (89) The US company Novavax developed the Covid-19 vaccine that was 89.3 percent effective in the Phase Three trial in the UK, but at a lower rate with the South African strain. Novavax's two-injected NVV-CoV2373 vaccine is also highly effective with the new CoV variant recently discovered in the UK. Covid-19 vaccine from the American biotechnology company Novavax Photo: Reuters ...
Kara McKinney
Steve Alcorn
Angela Akenson
Davey Abu Dhabi
Meli Tuiavi'i
Leno Fountain
David Woods
Joyce Thalacker-Hudson
Christopher Fawcett
Ella Baesso
Cory D Young
Derek Hall
Demauri Brunson
Leo Bellamy
Travis Miles
Zhai Ambion Castro
Tina Hernandez
Let the flashbacks begin
Ramonito Tragico Jr.
Kara McKinney
Steve Alcorn
Angela Akenson
Davey Abu Dhabi
Meli Tuiavi'i
Leno Fountain
David Woods
Joyce Thalacker-Hudson
Christopher Fawcett
Ella Baesso
Cory D Young
Derek Hall
Demauri Brunson
Leo Bellamy
Travis Miles
Zhai Ambion Castro
Tina Hernandez
Akarshan Lochun
Akarshan Lochun